"Nanoconjugates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tailored macromolecules harboring covalently-bound biologically active modules that target specific tissues and cells. The active modules or functional groups can include drugs, prodrugs, antibodies, and oligonucleotides, which can act synergistically and be multitargeting.
| Descriptor ID |
D058726
|
| MeSH Number(s) |
D26.255.260.600 E02.319.300.380.600 J01.637.512.600.577
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nanoconjugates".
Below are MeSH descriptors whose meaning is more specific than "Nanoconjugates".
This graph shows the total number of publications written about "Nanoconjugates" by people in this website by year, and whether "Nanoconjugates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nanoconjugates" by people in Profiles.
-
Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors. Cancer Res. 2021 02 01; 81(3):763-775.
-
Characterization of a novel MR-detectable nanoantioxidant that mitigates the recall immune response. NMR Biomed. 2016 10; 29(10):1436-44.
-
Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma. Nanomedicine. 2014 Aug; 10(6):1121-30.
-
Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One. 2011; 6(6):e20347.